General practitioners' adherence to the COPD GOLD guidelines: Baseline data from the Swiss COPD Cohort Study

Swiss Medical Weekly

Volumn 140, Issue AUGUST, 2010, Pages

  Jochmann, Anja ^a   Neubauer, Falk ^a   Miedinger, David ^a   Török, Salome Schafroth ^a   Chhajed, Prashant N ^a   Tamm, Michael ^a   Leuppi, Jörg D ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Bronchodilators; COPD; GOLD; Guidelines; Inhaled corticosteroids; Management; Primary care; Pulmonary rehabilitation

Indexed keywords

ACETYLCYSTEINE; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; METHYLXANTHINE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEMOGRAPHY; DISEASE COURSE; EXERCISE; FEMALE; GENERAL PRACTITIONER; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PULMONARY REHABILITATION; QUESTIONNAIRE; SPIROMETRY; SWITZERLAND;

EID: 80955169343     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2010.13053     Document Type: Article

References (29)

1. Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med. 1997;156:814-8. (Pubitemid 27396420)
2. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436-42. (Pubitemid 27212192)
3. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Update 2008.
4. Russi EW, Leuenberger P, Brändli O, et al. Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society. Swiss Med Wkly. 2002;132:67-78. (Pubitemid 34311008)
5. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256-76. (Pubitemid 32378468)
6. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532-55. (Pubitemid 47403272)
7. Buffels J, Degryse J, Decramer M; DIDASCO Study. Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest. 2004;125:1394-9. (Pubitemid 38501355)
8. Wouters EF. The burden of COPD in The Netherlands: results from the Confronting COPD survey. Respir Med. 2003;97(Suppl C):S51-9. (Pubitemid 36266870)
9. © Bundesamt für Statistik, N. Anzahl und Dichte der berufstätigen Ärzte und Zahnärzte. 2007. http://www.bfs.admin.ch/ bfs/portal/de/index/themen/14/03/03/key/01.html.
10. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1994;152:1107-36.
11. Perez-Padilla R, Vazquez-Garcia JC, Márquez MN, et al. The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care. 2006;51:1167-71.
12. Brändli O, Schindler C, Künzli N, Keller R, Perruchoud AP. Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population. Thorax. 1996;51:277-83. (Pubitemid 26086472)
13. Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Respirology. 2005;10:9-17.
14. Rutschmann OT, Janssens JP, Vermeulen B, Sarasin FP. Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med. 2004;98:932-7. (Pubitemid 40029123)
15. Schneider A, Gantner L, Maag I, Borst MM, Wensing M, Szecsenyi J. Are ICD-10 codes appropriate for performance assessment in asthma and COPD in general practice? Results of a cross sectional observational study. BMC Health Serv Res. 2005;5:11.
16. Jones RC, Dickson-Spillmann M, Mather MJ, Marks D, Shackell BS. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res. 2008;9:62.
17. Yawn BP. Differential assessment and management of asthma vs chronic obstructive pulmonary disease. Medscape J Med. 2009;11:20.
18. Schermer TR, Jacobs JE, Chavannes NH, Hartman J, Folgering HT, Bottema BJ, van Weel C. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax. 2003;58:861-6. (Pubitemid 37239233)
19. Leuppi JD, Miedinger D, Chhajed PN, Buess C, Schafroth S, Bucher HC, Tamm M. Quality of spirometry in primary care for case finding of airway obstruction in smokers. Respiration. 2010;79(6):469-74. Epub 2009 Sep 26.
20. Evans RA, Singh SJ, Collier R, Williams JE, Morgan MD. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med. 2009;103:1070-5 [E-pub 13 Feb 2009].
21. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543-54.
22. Tashkin DP, Donohue JF, Mahler DA, et al. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Respir Med. 2009;103:516-24.
23. Bourbeau J, Sebaldt RJ, Day A, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J. 2008;15:13-9. (Pubitemid 351575058)
24. Gartlehner G, Hansen RA, Carson SS, Lohr KN, et al. Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Ann Fam Med. 2006;4:253-62. (Pubitemid 43824800)
25. Calverley PM, Anderson JA, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775-89. (Pubitemid 46294610)
26. Crim, C., P. M. Calverley, et al. "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." Eur Respir J. 2009;34(3):641-7.
27. Vondracek SF, Hemstreet BA. Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease? Pharmacotherapy. 2006;26:522-32.
28. Siebeling L, Ter Riet G, van der Wal WM, et al. ICE COLD ERIC - International Collaborative Effort on Chronic Obstructive Lung Disease: Exacerbation Risk Index Cohorts - study protocol for an international COPD cohort study. BMC Pulm Med. 2009;9:15.
29. Miedinger D, Linz A, Praehauser C, Chhajed PN, Buess C, Schafroth Török S, Bucher HC, Tamm M, Leuppi JD. Patient-reported respiratory symptoms and pre-bronchodilator airflow limitation among smokers in Switzerland. Prim Care Respir J. 2010;19(2):163-9.